<DOC>
	<DOCNO>NCT02170103</DOCNO>
	<brief_summary>The investigator propose test effectiveness technique use modify commercially available ultrasound system use cardiac imaging , commercially available ultrasound contrast agent ( microbubbles ) break blood clot cause heart attack . The ultrasound microbubbles apply soon possible patient present emergency department , EKG confirm heart attack ongoing . Patients provide emergent consent randomize either conventional therapy heart attack , conventional therapy ultrasound microbubbles . The ultrasound applied emergent heart catheterization , order break blood clot artery supply heart muscle , also small branch ( capillary ) feed artery . Following randomized treatment , patient follow development complication ( recurrent heart attack , heart failure , need defibrillator placement ) well echo cardiac MRI determine much heart muscle salvage treatment . A total 250 patient enrol follow two different site . Randomization stratify study site . The initial site enrol patient University Sao Paulo Medical School . Wilson Mathias , MD , serve principal investigator site . The VU University Medical Center Amsterdam , Otto Kamp , MD , serve principal investigator .</brief_summary>
	<brief_title>Microvascular Reperfusion Utilizing Sonothrombolysis Acute Myocardial Infarction ( MRUSMI TRIAL )</brief_title>
	<detailed_description />
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<mesh_term>Chest Pain</mesh_term>
	<criteria>Patients present participate center chest pain EKG evidence acute STEMI ( two contiguous lead &gt; 0.1 mV ST elevation &gt; 0.1 ST depression V2V4 ) ask participate . The inclusion criterion : 1 . Age â‰¥30 year . 2 . Eligible emergent PCI/antithrombotic/antiplatelet therapy . 3 . Adequate apical and/or parasternal image echocardiography . 4 . No contraindication hypersensitivity ultrasound contrast agent . 1 . Known suspected hypersensitivity ultrasound contrast agent use study . 2 . Cardiogenic Shock 3 . Life expectancy less two month terminally ill. 4 . Known severe cardiomyopathy . 5 . Known bleed diathesis contraindication glycoprotein 2b/3a inhibitor , anticoagulant , aspirin 6 . Known large right leave intracardiac shunt .</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2014</verification_date>
	<keyword>segment elevation myocardial infarction ( STEMIs ) ,</keyword>
	<keyword>sonothrombolysis</keyword>
	<keyword>reperfusion</keyword>
	<keyword>percutaneous intervention ( PCI ) ,</keyword>
	<keyword>antithrombotic therapy ,</keyword>
	<keyword>antiplatelet therapy ,</keyword>
</DOC>